Skip to main content
VANI
NASDAQ Industrial Applications And Services

Director Gregg Williams Deepens Conviction with Another $1M Vivani Medical Purchase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.41
Mkt Cap
$121.591M
52W Low
$0.923
52W High
$1.92
52W Position info
53% above low
Off High info
27% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

VANI sits 53% above its 52-week low of $0.923.

Summary

Director and 10% owner Gregg Williams bought another $1M in Vivani Medical stock, continuing a pattern of heavy insider accumulation amid positive clinical and partnership developments.


Key Events · Ownership and Investor Activity · VANI

  • Williams Buys $1M More Stock

    Under a pre-existing August 2025 agreement, director and 10% owner Gregg Williams purchased 793,650 shares at $1.26 per share for a total of $999,999 on July 15, 2026.

  • Accumulation Pattern Continues

    This is Williams' third open-market purchase in three months, totaling $4M, following $2M on May 19 and $1M on June 16, signaling strong insider conviction.

  • Post-Transaction Stake

    Williams now holds 36,912,736 shares directly and indirectly, representing approximately 30% of the company's outstanding shares.

  • Positive Clinical and Partnership Backdrop

    The purchase follows successful first-in-human trial results for NPM-139 and a Novo Nordisk evaluation agreement, both announced in recent weeks.


Analysis · VANI · Industrial Applications And Services

On July 15, 2026, director and 10% owner Gregg Williams acquired $999,999 worth of Vivani Medical common stock at $1.26 per share. This marks his third substantial open-market purchase in three months, following $2M on May 19 and $1M on June 16, bringing his total recent investment to $4M. The $1.26 price was set under a pre-existing agreement from August 2025, representing a discount to the current $1.41 market price. Williams now controls 36.9 million shares, reinforcing his conviction in the company's GLP-1 implant pipeline, which recently achieved positive clinical milestones and a Novo Nordisk evaluation agreement.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VANI was trading at $1.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $121.6M. The 52-week trading range was $0.92 to $1.92. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Nov 16, 2026, 5:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $1.12 info
Change: +$0.070 (+7%) info
Market Cap: $101.028M info
VANI
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $1.12 info
Change: -$0.0618 (-5%) info
Market Cap: $101.028M info
VANI
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.12 info
Change: -$0.050 (-4%) info
Market Cap: $101.028M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.12 info
Change: -$0.0100 (-0.88%) info
Market Cap: $101.028M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.12 info
Change: -$0.220 (-16%) info
Market Cap: $101.028M info